: Patients in clinical trials were generally younger, with a mean age of 58 compared to 61 in this real-world group.

Explain the specific (toxicities) that led to these discontinuations. Compare these results to more recent ibrutinib studies .

: For those who stopped the medication, the median time until they did so was only 7 months .

: Investigating approaches where patients only take the drug for a set period, especially if they achieve a complete response, to avoid unnecessary long-term exposure and side effects. If you'd like, I can:

: Both groups had roughly the same time (about 85–87 months) from their initial diagnosis until they started ibrutinib treatment. Clinical Implications

The authors argue that because the drug is highly effective but often hard to tolerate, the medical community should focus on:

Provide a breakdown of the used by the researchers in this study. Which of these would be most helpful for you?

The search for a "616 KB" article points directly to a significant medical study titled